Navigation Links
New Study Linking 'High Normal' Blood Pressure to Significant Cardiovascular Risk
Date:5/28/2008

- AtCor Medical's SphygmoCor system plays key role in discovery

ITASCA, Ill. and SYDNEY, Australia, May 28 /PRNewswire-FirstCall/ -- A new study of more than 10,000 patients, conducted by the Universities of Cambridge and Cardiff in the United Kingdom using AtCor Medical Holdings Limited's SphygmoCor(R) has found that more than 70 percent of patients identified as having "high normal" systolic blood pressure through traditional cuff blood pressure measurement may be at serious cardiovascular risk. This is because those individuals have elevated central systolic blood pressure, which is associated with increased incidence of heart attack, stroke and kidney disease. SphygmoCor(R) is a non-invasive central blood pressure assessment technology that has been used by researchers over the past several years.

The Anglo Cardiff Collaborative Trial, a cooperative effort of the Universities of Cambridge and Cardiff in the United Kingdom, tracked the blood pressure of 10,613 patients with two systems -- traditional blood pressure measurement using an inflatable arm cuff, and non-invasive central blood pressure assessment using SphygmoCor(R). The investigators found that more than 70 percent of patients with brachial systolic blood pressure in the "high normal" range (130-139 mm Hg) had central systolic blood pressures corresponding to those seen in patients with Stage One Hypertension (140-159 mm Hg measured brachially). Treatment guidelines call for anti-hypertensive drug therapy for stage one hypertension whereas life-style changes only are guided in the "high normal" range. Elevated central pressure was also found to be associated with an increase in cardiovascular risk factors.

"The real significance of these findings is that central and brachial blood pressures are not the same, meaning that central pressure cannot simply be inferred from the brachial pressure measurement, but should also be assessed," said Dr. Carmel McEniery, the study's lea
'/>"/>

SOURCE AtCor Medical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids
2. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
3. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
4. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
5. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
6. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
7. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
8. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
9. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
10. Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results
11. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015  Trovagene, Inc. (NASDAQ:  TROV), a developer ... results for the three months ended March 31, ... we presented favorable clinical results at ASCO GI, ... our Precision Cancer Monitoring platform,s ability to detect ... lung cancers," said Antonius Schuh, Ph.D., chief executive ...
(Date:5/5/2015)... LAVAL, QC , May 5, 2015 /CNW Telbec/ ... in Laval and known under ... announces today the closing of the transaction previously announced ... of the issued and outstanding  shares of Orthoconcept (2008) ... by issuing 500 000 common shares (TSXV: ERG) to ...
(Date:5/5/2015)... Valley Medical Center, named a Top 100 Hospitals® in the ... to deploy the wireless Leaf Patient Monitoring System in its ... labor and risk of caesarian births. Studies show ... is reduced in mothers who are upright and mobile during ... epidurals and tend to lie in their labor room beds. ...
Breaking Medicine Technology:Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4
... 11, 2011 Tonight,s "Dan Rather Reports" examines ... of antibiotics. Every year, more than 90,000 Americans ... antibiotic-resistant infections, caused directly by the overuse of ... $35 billion a year.  In tonight,s program, Dan ...
... 2011 WebMD Health Corp. (Nasdaq: WBMD ) ... million aggregate principal amount of 2.50% Convertible Notes due 2018 ... the exercise in full of the initial purchaser,s over-allotment option). ... to Rule 144A under the Securities Act of 1933.   ...
Cached Medicine Technology:Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 2Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 3Dan Rather Reports Investigates our Heavy Dependence on Antibiotics - What are the Causes... and the Consequences? 4WebMD Closes Offering of 2.50% Convertible Notes Due 2018 2
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 With ProPoint: ... all within Final Cut Pro X . With ... within 3D space to further more customize each preset all ... users are given up to 90 fully customizable effect presets ... boxes, circles, curved arrows, straight arrows, underlines, and more. ...
(Date:5/5/2015)... Cosmetic Dentist, Arthur Glosman released a luxury line of advanced ... offices of Arthur Glosman DDS, 450 N Roxbury Drive Suite ... store . “I wanted to be one of the first ... with a luxurious collection of products designed to make you ... Glosman’s Advanced Dental Health + Beauty™ products use a potent ...
(Date:5/5/2015)... New Jersey (PRWEB) May 05, 2015 ... has maintained its strong and secure credit rating of ... of Horizon BCBSNJ’s financials last week, the Wall Street ... adequacy” and “leading market position” in determining the rating ... of mind is one of our top priorities, so ...
(Date:5/5/2015)... 05, 2015 Hundreds of ... on behalf of men who allegedly suffered ... of prescription testosterone replacement therapies continue to ... underway in U.S. District Court, Northern District ... May 1st, defendants AbbVie, Inc., Auxilium Pharmaceuticals, ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great ... runners and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... , The 5K and 10K runs and 1-and 3-mile walks ... raise funds for tick-borne disease research. The “Lyme Walk and ... merger of Lyme Research Alliance (LRA) and Tick-Borne Disease ...
Breaking Medicine News(10 mins):Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3
... sensitive tooth at some point of their life. A visit to ... or 'you brush in a hard way, so your teeth are ... out with a solution that could make sensitive teeth a bad ... out the dentinal tubules which transmit painful signals to the pulp, ...
... to fund a study which helps to understand the ... to breast cancer patients to ease the pain they ... study is to be carried out by Researchers from ... the three complementary therapy methods reflexology, guided imagery and ...
... one of the most common breathing problems encountered by ... has been a considerable increase in the incidence of ... been estimated that nearly 196,000 children are hospitalized in ... considerable amount is being spent on the health issue ...
... loss of motor function in a part due to ... Lateral Sclerosis// is a form of motor neuron disease ... incapable of even the slightest movements such as blinking. ... ,The new headband that has been developed by Japanese ...
... year India’s Health care has been in constant limelight ... the healthcare system in India came to focus after ... the City leaving thousands homeless, many orphaned and a ... worked quickly and effectively with the people providing immediate ...
... Phase II study to 12 months confirm the significant effects ... patients with relapsing multiple sclerosis (MS). ,The data, ... both patient groups taking FTY720 (1.25 mg and 5 mg) ... of more than 50% during the first six months of ...
Cached Medicine News:Health News:Improved parent-physician communication to prevent hospitalizations for childhood asthma 2Health News:Novartis MS Drug Shows Promising Results 2Health News:Novartis MS Drug Shows Promising Results 3
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... placement to stent the ureter ... continent urinary diversions. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... remain indwelling more than six ...
... The Bard® C-Max™ Cutting Loop is ... smooth tissue cut. The cutting loops are ... standard. The tungsten wire-cutting loop is hand ... process. These electrodes are made to exacting ...
Medicine Products: